Stockreport

I-Mab Reports Full Year 2024 Financial Results and Provides Business Update

I-MAB - American Depositary Shares  (IMAB) 
PDF Continued positive momentum in givastomig Phase 1b combination trial in first-line gastric cancer, with topline dose escalation data (n=17) expected in 2H 2025Enrollment [Read more]